Sanofi Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 21 New Drug Applications and 62 Abbreviated New Drug Applications; Correction

Краткое содержание

The Food and Drug Administration (FDA) is correcting a document that appeared in the Federal Register of May 12, 1998 (62 FR 26191). The document announced the withdrawal of approval of 21 new drug applications (NDA's) and 62 abbreviated new drug applications (ANDA's). The document was published with an error in the identification of NDA for Pipanol Powder and Tablets (trihyphenidyl) held by Sanofi Pharmaceuticals, Inc. This document corrects that error.